Evotec/Oxford Asymmetry To Exchange Technology For Equity Investments
Executive Summary
The Evotec/Oxford Asymmetry merged company will look to license technology in exchange for equity investments in new ventures, Evotec CEO Karsten Henco, PhD, said during a July 31 conference call.